Stockscreener 앱 받기
136.67
0.51%
-0.70
시장 영업 전:
138.80
2.13
+1.56%
전일 마감가:
$137.37
열려 있는:
$139.38
하루 거래량:
1.13M
Relative Volume:
0.61
시가총액:
$21.68B
수익:
$4.39B
순이익/손실:
$-1.58B
주가수익비율:
-13.72
EPS:
-9.96
순현금흐름:
$546.00M
1주 성능:
-0.01%
1개월 성능:
-4.51%
6개월 성능:
+14.00%
1년 성능:
+2.33%
1일 변동 폭
$136.49
$140.33
1주일 범위
$131.75
$153.06
52주 변동 폭
$100.08
$156.66
일루미나 Stock (ILMN) Company Profile
명칭
Illumina Inc
전화
(858) 202-4500
주소
5200 ILLUMINA WAY, SAN DIEGO, CA
ILMN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
136.67 | 21.68B | 4.39B | -1.58B | 546.00M | -9.96 |
|
TMO
Thermo Fisher Scientific Inc
|
559.65 | 214.07B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
238.36 | 172.16B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
147.36 | 42.09B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.36 | 35.82B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
419.26 | 34.33B | 3.84B | 866.24M | 792.60M | 10.37 |
일루미나 Stock (ILMN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-11-12 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-10-17 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-08-28 | 업그레이드 | Argus | Hold → Buy |
| 2024-08-16 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-08-14 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-14 | 개시 | Stephens | Overweight |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-12-11 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-11-10 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | 개시 | Bernstein | Underperform |
| 2023-07-05 | 재개 | JP Morgan | Neutral |
| 2023-01-25 | 다운그레이드 | Argus | Buy → Hold |
| 2023-01-05 | 개시 | Scotiabank | Sector Perform |
| 2022-12-12 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-04 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-07-13 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-01-18 | 업그레이드 | Stifel | Hold → Buy |
| 2022-01-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2022-01-07 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-19 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2021-03-31 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | 개시 | Barclays | Underweight |
| 2020-12-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-10-13 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-09-22 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-09-21 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-09-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-08-07 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-08-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-24 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-04-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-10-25 | 개시 | Guggenheim | Buy |
모두보기
일루미나 주식(ILMN)의 최신 뉴스
Illumina, Inc. (NASDAQ:ILMN) Stock Holdings Raised by Assenagon Asset Management S.A. - MarketBeat
Genetic Testing Market Projected To Witness Substantial Growth, 2025-2032: Eurofins Scientific, Illumina Inc., - EIN News
Cancer Biopsy Market Size is Expected to Reach USD 60.92 Billion by 2033, Growing at a CAGR of 7.81%: Straits Research - GlobeNewswire Inc.
Illumina, Inc.'s (NASDAQ:ILMN) Price Is Out Of Tune With Revenues - Simply Wall St
Illumina, Inc. (NASDAQ:ILMN) Receives $165.63 Average PT from Analysts - MarketBeat
Microfluidics Market Poised for Substantial Growth (2025-2032) | PerkinElmer, Agilent Technologies, Inc., Illumina. - openPR
Key Trends in the Bioinformatics Market with Insights from - openPR
Sax Wealth Advisors LLC Purchases Shares of 4,198 Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Avanza Fonder AB Buys Shares of 17,599 Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina Partners NVIDIA for Genomic Advancements, ILMN Stock Climbs - MSN
JP Morgan 2025: analysts remain doubtful of Illumina’s growth - MSN
Gateway Investment Advisers LLC Raises Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Video: The first NovaSeq X in the Benelux region is a “game changer” - Illumina
Bioinformatics Market Analysis, Size, Share, and Growth - openPR
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by Sicart Associates LLC - MarketBeat
Whole Exome Sequencing Market Overall Study Report 2025-2032 | - openPR
Global Single Cell Bioinformatics Software and Service Market - openPR
Why Illumina (ILMN) is Poised to Beat Earnings Estimates Again - Yahoo Finance
Beech Hill Advisors Inc. Has $1.92 Million Stock Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina, Inc. (NASDAQ:ILMN) Short Interest Update - MarketBeat
10,833 Shares in Illumina, Inc. (NASDAQ:ILMN) Acquired by USA Financial Formulas - MarketBeat
Lab-on-a-chip and Microarrays (Biochip) Market Future - openPR
Biomarker Research Services Market Projected To Witness Substantial Growth, 2025-2032:Abbott Laboratories, - EIN News
Illumina (NASDAQ:ILMN) Trading Up 5.7%Time to Buy? - MarketBeat
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2024 and Provides Preliminary Outlook for Fiscal Year 2025 - Longview News-Journal
Illumina, Inc. (NASDAQ:ILMN) Shares Acquired by CCLA Investment Management - MarketBeat
Illumina, Nvidia Launch AI-Based Genomics Partnership - Genetic Engineering & Biotechnology News
Future-Proofing Growth of DNA Data Storage Market, Size, - openPR
Molecular Diagnostics Market Size, Share & Business Opportunities forecast by 2031 | F. Hoffmann-La Roche Ltd, - EIN News
RNA Sequencing Market 2024-2031 Global Industry Analysis, - openPR
Illumina CEO Highlights Genomics Future and Nvidia Partnership at JPMorgan Health-Care Conference - HPBL
Genomic Cancer Testing Market Future Business Opportunities - openPR
Illumina partners with Nvidia on AI-powered genomic sequencing - MSN
Illumina reports preliminary Q4 results, provides 2025 expectations - MSN
Illumina CEO Thaysen on Nvidia Partnership, Genomics, M&A - Marketscreener.com
Nvidia Announces Partnerships with Mayo Clinic, Illumina & More at JPM25 - Dealbreaker
Illumina Raises Q4 Revenue Outlook To $1.10 Billion, Exceeding Street Expectations; Sees Solid Margins - Benzinga
Illumina (NASDAQ:ILMN) Issues FY 2024 Earnings Guidance - MarketBeat
Illumina posts modest Q4 revenue growth, anticipates 2025 rise - Investing.com
Illumina (NASDAQ:ILMN) Issues Q4 Earnings Guidance - MarketBeat
Illumina stock falls on 2025 outlook miss By Investing.com - Investing.com Australia
Illumina, Nvidia collaborate to decode biology and propel precision health - Yahoo Finance
Illumina stock falls on 2025 outlook miss - Investing.com
Truveta sells stakes to Regeneron, Illumina in deal to build genetic database - MSN
Nvidia (NVDA) Expands Healthcare Presence with Illumina Partnership - TipRanks
Illumina (NASDAQ:ILMN) Trading 5.7% HigherWhat's Next? - MarketBeat
Illumina partners with NVIDIA for advanced genomics analysis By Investing.com - Investing.com Canada
Morgan Stanley Cuts Illumina (NASDAQ:ILMN) Price Target to $150.00 - MarketBeat
Illumina, Nvidia team to use AI in foundation models - MedTech Dive
Illumina and Regeneron invest $139.5m in Truveta to build largest genetic database - Yahoo Finance
Illumina and NVIDIA Just Dropped a Genomics Bombshell - GuruFocus.com
일루미나 (ILMN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
자본화:
|
볼륨(24시간):